Erlotinib-induced generalized eczema craquelé and follicular rash sparing the previous radiation field.
H Y
HY
Chiu
Y P
YP
Cheng
S H
SH
Jee
T F
TF
Tsai
D000230:Adenocarcinoma / Q000188:drug therapy / Q000532:radiotherapy; D003131:Combined Modality Therapy; D003875:Drug Eruptions / Q000209:etiology*; D004485:Eczema / Q000139:chemically induced*; D000069347:Erlotinib Hydrochloride; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride